![Henry Ji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henry Ji
Directeur Général chez
SCILEX HOLDING COMPANY
Fortune : 172 393 $ au 31/05/2026
Profil
Henry H.
Ji is the founder of Sorrento Therapeutics, Inc., founded in 1989, serving as Chairman, President & Chief Executive Officer since 2017.
Dr. Ji is the founder of BioVintage, Inc., founded in 2002, serving as President since 2002.
Dr. Ji was the founder of Stratagene Genomics, Inc., founded in 1997, serving as President, Chief Executive Officer & Director from 1997 to 1999.
Dr. Ji was the founder of Sorrento Therapeutics, Inc., founded in 2006, serving as Director & Chief Scientific Officer (no longer active).
Current jobs include Chief Executive Officer & Chief Financial Officer at Scintilla Pharmaceuticals, Inc.; Executive Chairman, President & CEO at Semnur Pharmaceuticals, Inc. starting 2026; Chief Executive Officer & Secretary at Semnur, Inc. since 2013; Executive Chairman, President & CEO at Scilex Holding Co. starting 2025; Director at Scilex Pharmaceuticals, Inc. since 2016; and Director at Elsie Biotechnologies Inc. Former jobs include Executive Chairman at Scilex, Inc. from 2019 to 2022; Executive Chairman at Scilex Holding Co. from 2019 to 2023; Director at NantKwest, Inc. from 2014 to 2015; Director-Business Development at Stratagene Corp.
from 1999 to 2001; Managing Director at Hongye SD Group LLC; Director at Celularity, Inc. from 2017 to 2021; Vice President at CombiMatrix Corp.
from 2001 to 2002; and Secretary & Chief Scientific Officer at Quikbyte Software, Inc. in 2009.
Education includes a doctorate from the University of Minnesota and an undergraduate degree from Fudan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCILEX HOLDING COMPANY 0,23 % | 28/04/2026 | 19 370 ( 0,23 % ) | 172 393 $ | 31/05/2026 |
-.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Henry Ji
| Sociétés | Poste | Début |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Directeur Général | 01/04/2011 |
| SCILEX HOLDING COMPANY | Directeur Général | 17/08/2025 |
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Directeur/Membre du Conseil | - |
Scilex Pharmaceuticals, Inc.
 Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management products | Directeur/Membre du Conseil | 01/11/2016 |
Scintilla Pharmaceuticals, Inc.
 Scintilla Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and commercializes pharmaceutical products | Directeur Général | - |
BioVintage, Inc.
 BioVintage, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a research and development company which focuses on innovative life science technology and product development | Fondateur | 01/01/2002 |
Semnur, Inc.
 Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Directeur Général | 01/01/2013 |
Anciens postes connus de Henry Ji
| Sociétés | Poste | Fin |
|---|---|---|
| SCILEX HOLDING COMPANY | Président | 01/08/2023 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Président | 01/11/2022 |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Henry Ji
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
CombiMatrix Corp.
 CombiMatrix Corp. Medical/Nursing ServicesHealth Services Provides molecular diagnostic services | Health Services |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Quikbyte Software, Inc.
 Quikbyte Software, Inc. Financial ConglomeratesFinance Development Stage Company | Finance |
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management products | Health Technology |
Stratagene Corp.
 Stratagene Corp. Medical SpecialtiesHealth Technology Researches and develops diagnostic products | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc. /Old/
 Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops human monoclonal antibodies | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
BioVintage, Inc.
BioVintage, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a research and development company which focuses on innovative life science technology and product development | Commercial Services |
Stratagene Genomics, Inc. | |
Hongye SD Group LLC | |
Scintilla Pharmaceuticals, Inc.
Scintilla Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and commercializes pharmaceutical products | Retail Trade |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Commercial Services |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
